SIBO Breath Test: Normal Ranges, Optimal Targets, and What Longevity Medicine Recommends

What the SIBO Breath Test Actually Measures

The test captures two fermentation gases produced by bacteria in the small intestine. Fasting samples establish baseline, and serial samples taken every 15 to 20 minutes after substrate ingestion track gas curves over 2 to 3 hours.

Human cells cannot produce H2 or CH4. Any exhaled H2 or CH4 therefore reflects microbial metabolism. When bacteria are abnormally located in the small bowel, they ferment the substrate before it reaches the colon, producing an early gas peak that distinguishes SIBO from colonic fermentation.

The Two Primary Gases

Hydrogen (H2) is produced by fermentative bacteria, principally Enterobacteriaceae, Lactobacillaceae, and Bacteroidetes species. A sharp early rise within the first 90 minutes of a lactulose challenge is the signature pattern of hydrogen-dominant SIBO.

Methane (CH4) is produced almost exclusively by a domain of archaea called methanogens, particularly Methanobrevibacter smithii. Elevated CH4 at any point in the test, regardless of when the peak occurs, constitutes a positive result under both the 2017 North American Consensus guidelines and the updated 2020 ACG Clinical Guideline on SIBO [1][2].

The Emerging Third Gas: Hydrogen Sulfide

Hydrogen sulfide (H2S) SIBO is detectable only on newer three-gas analyzers. Standard two-gas devices will show a flat H2 and CH4 curve in these patients, historically called a "flat-line" SIBO pattern. The American College of Gastroenterology notes that H2S breath testing remains investigational, but preliminary data suggest an optimal target of <2 ppm at any point [2]. Clinicians ordering breath tests for longevity workups should specify a three-gas device where available.

Conventional Positive and Negative Reference Ranges

Standard laboratory reference ranges come from the 2017 North American Consensus Statement, which was signed by 17 gastroenterology societies and represents the most widely cited authority on breath-test interpretation [1].

Hydrogen Cutoffs

A rise in exhaled H2 of ≥20 ppm above fasting baseline within the first 90 minutes of a lactulose breath test is considered positive for SIBO [1]. For glucose breath tests, the same 20 ppm rise criterion applies, but because glucose is fully absorbed in the proximal small bowel, a positive result within 60 minutes carries higher specificity.

The 2017 Consensus explicitly rejected the older two-peak criterion (early small-bowel peak followed by a colonic peak), noting that mouth bacteria can generate an artifactual first peak. Clinicians should not diagnose SIBO on an isolated early spike that resolves before the 90-minute window and is not sustained.

| Gas | Conventional Negative | Conventional Positive | Longevity Optimal | |---|---|---|---| | Fasting H2 | <20 ppm | ≥20 ppm | <5 ppm | | H2 rise at 90 min | <20 ppm rise | ≥20 ppm rise | <10 ppm rise | | CH4 (any point) | <10 ppm | ≥10 ppm | <3 ppm | | H2S (3-gas device) | <5 ppm | ≥5 ppm | <2 ppm |

Methane Cutoffs

The 2017 Consensus designated CH4 ≥10 ppm at any sample point as positive, reflecting the observation that methanogens colonize the proximal intestine and do not produce a strictly time-dependent curve [1]. This pattern is sometimes called intestinal methanogen overgrowth (IMO) to distinguish it from the bacterial-origin SIBO that produces hydrogen.

A prospective study (N=210) published in Digestive Diseases and Sciences found that CH4 levels ≥10 ppm correlated with constipation-predominant IBS symptoms in 74% of subjects, consistent with methane slowing intestinal transit time [3].

What "Normal" Means on a Conventional Report

A negative result means no gas met the positive threshold. This does not mean zero bacterial colonization of the small bowel; it means colonization, if present, did not exceed the fermentation threshold detectable by the test. Low-grade overgrowth below the conventional positive cutoff can still cause symptoms and may still carry metabolic consequences in a longevity context.

Longevity-Medicine Target Ranges: Going Beyond "Not Positive"

Longevity medicine interprets labs differently than acute-disease medicine. The goal is not merely absence of pathology but optimization of function, and SIBO breath test values are no exception.

Why the Conventional Cutoff Is a Floor, Not a Ceiling

The ≥20 ppm H2 cutoff was designed to distinguish SIBO from healthy controls in gastroenterology clinic populations. It was not designed to identify the optimal microbiome state for a 45-year-old pursuing healthspan extension. A fasting H2 of 18 ppm technically "passes" the conventional test but still represents a milieu of excessive small-bowel fermentation.

Intestinal permeability data support this interpretation. A 2020 study in Gut Microbes (N=120) found that fasting H2 values between 10 and 19 ppm correlated with significantly higher circulating lipopolysaccharide-binding protein (LBP) compared to subjects with fasting H2 <5 ppm, suggesting subclinical bacterial translocation even in the "negative" zone [4].

The Case for Fasting H2 <5 ppm

A fasting H2 <5 ppm represents near-zero small-bowel fermentation in the overnight-fasted state. This is the range consistently found in healthy long-lived populations and in clinical trial participants with no GI symptoms [1]. Several functional and integrative medicine programs, including protocols informed by the Institute for Functional Medicine's GI Advanced Practice Module, target this value as the threshold for a microbiome-friendly small intestine.

The HealthRX longevity gut protocol uses a three-tier interpretation framework:

1. Optimal (green): Fasting H2 <5 ppm, CH4 <3 ppm, H2S <2 ppm. No intervention indicated; standard gut-health maintenance.
2. Suboptimal (yellow): Fasting H2 5 to 19 ppm, CH4 3 to 9 ppm. Dietary and motility intervention; retest in 8 weeks.
3. Elevated (red): H2 rise ≥20 ppm or CH4 ≥10 ppm. Full SIBO treatment protocol; antibiotic or herbal eradication followed by reassessment.

Methane and Longevity

Methane gas itself may slow colonic and small-bowel transit, and chronic constipation carries independent associations with systemic inflammation and altered bile acid metabolism. A meta-analysis in Alimentary Pharmacology and Therapeutics (9 studies, N=1,283) found that methane positivity was associated with an odds ratio of 2.93 for constipation-predominant bowel patterns compared to methane-negative controls [5]. In a longevity context, targeting CH4 <3 ppm removes a potential driver of transit delay and the downstream metabolic dysfunction it produces.

How to Prepare for a SIBO Breath Test

Proper preparation is non-negotiable. The 2017 North American Consensus mandates a 12-hour fast before the test, avoidance of fermentable foods for 24 hours prior, no antibiotics for 4 weeks prior, and no prokinetics or laxatives for 1 week prior [1]. Failure to follow these instructions is the most common source of false positives and false negatives.

Day-Before Dietary Restrictions

The day before the test, subjects should eat only low-fermentable foods: plain white rice, plain white bread, plain baked or boiled chicken or fish, eggs, and water. This restricts substrate available to colonic bacteria so that baseline readings are truly low. Eating cruciferous vegetables, legumes, or high-fiber foods the night before will inflate fasting H2 and produce an uninterpretable result.

Medications That Affect Results

• Antibiotics (4-week washout required): Rifaximin, neomycin, metronidazole, or any broad-spectrum oral antibiotic will suppress SIBO and produce false negatives.
• Proton pump inhibitors: PPIs alter upper-GI microbiota. Ideally hold for 2 weeks if clinically safe; this is a shared decision with the prescribing physician.
• Opioids and anticholinergics: Slow transit, increasing colonic reflux of bacteria into the terminal ileum. Note their use on the requisition.
• Probiotics: Hold for 1 week. Live probiotic bacteria can ferment substrate and inflate H2.

Sample Collection Protocol

Each sample is a 500 mL end-expiratory breath collected into a sealed foil bag or a syringe-based device. The substrate dose is consumed at time zero after a baseline sample. Samples are then collected every 15 to 20 minutes for 2 to 3 hours, depending on the laboratory's protocol. Some labs use lactulose (10 g in 250 mL water); others use glucose (50 g or 75 g). Lactulose reaches the colon and therefore detects more distal SIBO; glucose is absorbed proximally and has higher specificity for proximal SIBO but lower sensitivity for ileal involvement [1].

Test Accuracy: Sensitivity, Specificity, and Why It Matters

No breath test is perfect. Clinicians and patients both need to understand the test's limitations before acting on results.

Sensitivity and Specificity by Substrate

A 2015 systematic review in the European Journal of Clinical Nutrition (14 studies) found that lactulose hydrogen breath testing had sensitivity of 52% and specificity of 86% for SIBO confirmed by jejunal aspirate culture [6]. Glucose breath testing showed sensitivity of 44% and specificity of 80% in the same review. These numbers are not impressive, and the authors concluded that a negative breath test does not reliably exclude SIBO, particularly when the clinical pretest probability is high.

The reference standard for SIBO diagnosis remains jejunal aspirate culture with a colony count ≥10^3 colony-forming units per mL, but this requires upper endoscopy and is impractical for routine clinical use [1][2]. Breath testing offers a non-invasive alternative with acceptable (though imperfect) accuracy.

False Positives

False positives occur when colonic bacteria reflux into the terminal ileum (e.g., absent ileocecal valve), when mouth bacteria are not adequately rinsed, or when the patient consumed fermentable foods the prior evening. A baseline H2 ≥20 ppm before substrate ingestion indicates poor preparation and should prompt test cancellation and rescheduling.

False Negatives

False negatives occur in patients who are poor H2 producers (approximately 15 to 20% of adults lack detectable H2-producing bacteria entirely), in patients who have recently used antibiotics, or in cases of H2S-dominant SIBO tested on a two-gas device. If clinical suspicion is high and breath testing is negative, a three-gas panel or empiric rifaximin trial is a reasonable next step [2].

SIBO Treatment: What the Evidence Supports

A positive SIBO breath test, or a longevity-suboptimal result on the HealthRX framework, calls for targeted intervention. Treatment options range from prescription antibiotics to herbal antimicrobials, with dietary and motility support as adjuncts.

Rifaximin for Hydrogen-Dominant SIBO

Rifaximin is the most studied antibiotic for SIBO. The TARGET 1 and TARGET 2 trials (combined N=1,258) established rifaximin 550 mg three times daily for 14 days as effective for IBS-D, with adequate relief in 40.7% of rifaximin patients versus 31.7% placebo (P<0.001) [7]. For SIBO specifically, a dose of 1,200 mg to 1,650 mg per day for 14 days is commonly used, though dosing varies by protocol. Rifaximin is minimally absorbed, acts locally in the gut, and has a favorable safety profile for repeated courses if needed.

Neomycin for Methane/IMO

Methane-positive SIBO responds less well to rifaximin alone. A randomized controlled trial (N=111) published in Digestive Diseases and Sciences found that the combination of rifaximin 1,200 mg/day plus neomycin 500 mg twice daily for 10 days normalized CH4 in 85% of patients versus 33% for rifaximin alone [8]. Neomycin targets M. Smithii directly, which explains the superior eradication rate.

Herbal Antimicrobials

For patients who prefer non-antibiotic options or who have had repeated antibiotic courses, herbal protocols are an evidence-based alternative. A 2014 study in Global Advances in Health and Medicine (N=104) found that herbal antimicrobial therapy (combining allicin, berberine, and oregano oil formulations) normalized breath test results in 46% of patients compared to 34% for rifaximin (difference not statistically significant at P = 0.24), suggesting comparable efficacy [9]. Herbal protocols typically run 4 to 6 weeks.

The Elemental Diet

A 2-week elemental diet (pre-digested amino acid formula) starves bacteria of fermentable substrate. A pilot study (N=93) reported by Pimentel et al. Found that 80% of patients normalized their breath tests after 2 weeks of elemental feeding [10]. This approach requires significant adherence but is particularly useful when antibiotics are contraindicated or when prior treatment has failed.

Post-Treatment Retesting

Retest 4 to 8 weeks after completing treatment, not sooner, because immediate post-treatment testing often shows transiently low gas values that rebound. The goal post-treatment is fasting H2 <5 ppm and CH4 <3 ppm, the longevity-optimal range, not merely dropping below the conventional positive threshold.

SIBO, Nutrient Malabsorption, and Biological Aging

The connection between SIBO and longevity is not speculative. Untreated bacterial overgrowth damages the brush border of the small intestine, reduces disaccharidase activity, and impairs absorption of fat-soluble vitamins (A, D, E, K), vitamin B12, and iron.

Vitamin D deficiency, found in a significant proportion of SIBO-positive patients, is independently associated with increased all-cause mortality in large epidemiological cohorts. The NHANES III analysis (N=13,331) reported a hazard ratio of 1.26 (95% CI, 1.08 to 1.46) for all-cause mortality in adults with serum 25(OH)D <17.8 ng/mL compared to those with higher levels [11].

Vitamin B12 malabsorption in untreated SIBO leads to elevated homocysteine, a well-established marker of vascular risk and biological aging. Supplementation corrects homocysteine only when the absorptive defect is also corrected, which means treating SIBO first, not just adding oral B12.

Ordering the Test: Clinical Indications and Practical Notes

Who Should Be Tested

The ACG 2020 Clinical Guideline recommends breath testing in patients with IBS, unexplained bloating, flatulence, diarrhea, weight loss, or documented nutrient deficiencies without a clear absorptive cause [2]. In a longevity medicine context, the HealthRX team also considers testing in:

• Adults with fasting LBP or zonulin above the 75th percentile on an intestinal permeability panel.
• Adults with confirmed low serum B12, ferritin, or fat-soluble vitamins despite adequate dietary intake and no other absorptive diagnosis.
• Adults post-bariatric surgery (ROUX-en-Y gastric bypass creates anatomical conditions that raise SIBO prevalence to 30 to 40% versus 6 to 15% in the general population) [2].
• Adults using proton pump inhibitors long-term (≥12 months), given documented pH-mediated shifts in upper-GI microbial composition.

Choosing a Lab

Home collection kits are available from Commonwealth Diagnostics International (CDI), QuinTron Instrument Company, and Aerodiagnostics, among others. Specify three-gas (H2, CH4, H2S) panels where available. Confirm the lab uses North American Consensus protocol sampling intervals (every 15 to 20 minutes for 120 minutes minimum with lactulose; 90 minutes is acceptable for glucose).

Interpreting Atypical Curves

A delayed gas rise appearing after the 90-minute mark on a lactulose test most likely represents colonic fermentation, not SIBO, because lactulose reaches the cecum in approximately 60 to 100 minutes in adults with normal transit. This should be reported as negative for SIBO. However, if the patient has documented slow transit (confirmed by colonic transit scintigraphy or radio-opaque marker study), the colonic arrival time may shift, and an experienced gastroenterologist should interpret the curve in context.